LC
LEGN icon

Lindbrook Capital’s Legend Biotech LEGN Stock Holding History

Lindbrook Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$5.46K Sell
161
-330
-67% -$11.8K ﹤0.01% 1915
2024
Q4 		$16K Buy
+491
New +$20.3K ﹤0.01% 1416

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lindbrook Capital's LEGN Position: Q1 2025 in Review

Lindbrook Capital reduced its Legend Biotech (LEGN) stake by 67% in Q1 2025, selling an estimated $11.8K and leaving 161 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Lindbrook Capital first reported a position in LEGN in Q4 2024 and has held it in 2 quarters since. The position peaked at $16K in Q4 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Lindbrook Capital held 161 shares of Legend Biotech worth $5.46K as of Q1 2025.
  • Lindbrook Capital sold 330 Legend Biotech shares in Q1 2025, an estimated $11.8K.
  • Legend Biotech made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1915 holding.
  • Lindbrook Capital first reported a position in Legend Biotech in Q4 2024 and has held it in 2 quarters since.
  • Lindbrook Capital's Legend Biotech position peaked at $16K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.